EVOKE PHARMA INC's ticker is and the CUSIP is 30049G203. A total of 11 filers reported holding EVOKE PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 5,580 | $9,207 | 0.00% |
| Concord Wealth Partners | 31 | $51 | 0.00% |
| CWM, LLC | 16 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 28 | $0 | 0.00% |
| VANGUARD GROUP INC | 29,851 | $49,254 | 0.00% |
| UBS Group AG | 1,107 | $1,827 | 0.00% |
| NewEdge Advisors, LLC | 208 | $343 | 0.00% |
| WELLS FARGO & COMPANY/MN | 17 | $28 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,894 | $34,266 | 0.00% |
| BlackRock Inc. | 1,473 | $2,431 | 0.00% |
This page lists EVOKE PHARMA INC's shareholders in Q2 2023. To view EVOKE PHARMA INC's shareholder history, click here.